FDA. 2011c. Communicating risks and benefits: An evidence-based user’s guide. http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/ucm268078.htm (accessed September 13, 2011).

FDA. 2011d. Advancing regulatory science at FDA: A strategic plan. http://www.fda.gov/downloads/scienceresearch/specialtopics/regulatoryscience/ucm268225.pdf (accessed September 13, 2011).

Getz, K., J. Wenger, R. Campo, E. Seguine, and K. I. Kaitin. 2008. Assessing the impact of protocol design changes on clinical trial performance. American Journal of Therapeutics 15(5):450-457.

Goetz, T. 2010. Sergey Brin’s search for a Parkinson’s cure. Wired 18(7). http://www.wired.com/magazine/2010/06/ff_sergeys_search/all/1 (accessed July 28, 2011).

HHS (Department of Health and Human Services). 2011. Principles of community engagement. Second edition. NIH Pub. 11-7782. http://www.atsdr.cdc.gov/communityengagement (accessed August 5, 2011).

Horowitz, C., and N. A. Bickell. 2011. Diabetes and cancer clinical trials: Innovative community partnerships with diverse populations. Speaker presentation at the Institute of Medicine Workshop on Public Engagement and Clinical Trials: New Models and Disruptive Technologies, June 27, New York.

IOM (Institute of Medicine). 2004. Health literacy: A prescription to end confusion. Washington, DC: The National Academies Press.

IOM. 2007. Learning what works best. The nation’s need for evidence on comparative effectiveness in health care. http://www.iom.edu/~/media/Files/Activity%20Files/Quality/VSRT/ComparativeEffectivenessWhitePaperF.ashx (accessed July 18, 2011).

IOM. 2008. Learning healthcare system concepts v.2008: Annual report: The Roundtable of Evidence Based Medicine. http://iom.edu/Activities/Quality/~/media/1697E98CE25D4CAB8A10D9A4ABCB7091.pdf (accessed August 22, 2011).

IOM. 2010a. Transforming clinical research in the United States: Challenges and opportunities: Workshop summary. Washington, DC: The National Academies Press.

IOM. 2010b. A national cancer clinical trials system for the 21st century: Reinvigorating the NCI Cooperative Group Program. Washington, DC: The National Academies Press.

IOM. 2011. Relieving pain in America: A blueprint for transforming prevention, care, education, and research. Washington, DC: The National Academies Press.

Kuehn, B. M. 2011. Patients go online seeking support, practical advice on health conditions. Journal of the American Medical Association 305(16):1644-1645.

Kush, R. D. 2011. Transforming medical research with electronic health records. iHealth Connections 1(1):16-20.

Lilford, R. J., and J. Jackson. 1995. Equipoise and the ethics of randomization. Journal of the Royal Society of Medicine 88:552-559.

Maitland, K., S. Kiguli, R. O. Opoka, C. Engoru, P. Olupot-Olupot, S. O. Akech, R. Nyeko, G. Mtove, H. Reyburn, T. Lang, B. Brent, J. A. Evans, J. K. Tibenderana, J. Crawley, E. C. Russell, M. Levin, A. G. Babiker, and D. M. Gibb for the FEAST Trial Group. 2011. Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine 364(26):2483-2495.

NCI (National Cancer Institute). 2010. NCI Cancer Bulletin. Special issue: Clinical trials enrollment. http://www.cancer.gov/ncicancerbulletin/051810/page5 (accessed September 27, 2011).

Neumann, J., J. Bras, E. Deas, S. O’Sullivan, L. Parkkinen, R. Lachmann, A. Li, J. Holton, R. Guerreiro, R. Paudel, B. Segarane, A. Singleton, A. Lees, J. Hardy, H. Houlden, T. Revesz, and N. W. Wood. 2009. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease. Brain 132:1783-1794.

NIH SMRB (National Institutes of Health Scientific Management Review Board). 2010. Report on the NIH Clinical Center. http://smrb.od.nih.gov/reports (accessed July 19, 2011).

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement